| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| May 4, 2026 | ±2.6% | +0.6% | over-priced |
| November 3, 2025 | ±1.6% | -0.5% | over-priced |
| August 4, 2025 | ±2.0% | -2.1% | under-priced |
| May 5, 2025 | ±2.5% | -2.8% | under-priced |
| November 4, 2024 | ±2.4% | +3.2% | under-priced |
| August 5, 2024 | ±2.2% | -1.8% | over-priced |
| April 29, 2024 | ±2.4% | +1.4% | over-priced |
| October 31, 2023 | ±2.1% | -0.0% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $1.00 | $85.1B | $4.5B |
| Q4 FY2025 | $1.54 | $82.3B | $6.6B |
| Q3 FY2025 | $1.76 | $85.3B | $7.8B |
| Q2 FY2025 | $1.64 | $81.5B | $7.4B |
Exxon Mobil Corporation (XOM) reports in 96 days, with the next report estimated for September 17, 2026. Across the last 8 reports, options priced an average ±2.2% earnings move while the stock actually moved 1.6% on average — the market has been roughly fair on XOM's earnings risk. Fundamentals into the print: EPS down 43.2% year-over-year, revenue up 2.4%. QuantLogix's live 5-factor engine currently reads XOM as a buy at 50/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →